Home/ Supplements/ Vitamin K/ Kid's Super Daily K2 22.5 mcg

Kid's Super Daily K2 22.5 mcg

product on market Liquid Carlson Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 is researched for its role in supporting bone health and calcium regulation. Evidence for these specific benefits is generally considered moderate to strong in clinical literature. This formulation focuses on a single nutrient to maintain these physiological functions.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Kid's Super Daily K2 22.5 mcg
Open Full PDF View on NIH DSLD →
Details

Label Data

0.03 mL
Serving Size
360
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

22.5 mcg
Within RDA (0.2× RDA) 275 studies (A:9, B:175)

Other Ingredients

Medium Chain Triglyceride Oil D-Alpha-Tocopherol Rosemary extract
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Children 4 years of age or older: take one drop daily or as directed by your healthcare professional. May be put in food or a drink.

Warnings & Precautions

Warning: Vitamin K can antagonize the effect of anticoagulants, including Warfarin. Do not take this product if you are taking Warfarin or are pregnant or breastfeeding without first consulting with your physician.

Formulation Notes

IGEN Non-GMO tested

Supports and promotes: Bone health Healthy blood Calcium assimilation Cardiovascular support Healthy development

Liquid Vitamin K

Vitamin K2 as MK-7 is one of the most important nutrients for developing healthy bones and helping to maintain children's strength long-term. Super Daily K2, derived from chickpeas, provides the most bioactive form of vitamin K2 in a single concentrated drop.

Gluten-free No artificial preservatives

Vegetarian

AN FDA Regulated Facility

Additional Information

IGEN Non-GMO tested

SFI Sustainable Forestry Initiative Certified Sourcing www.sfiprogram.org SFI-03531

Metadata

Product Details

DSLD Entry Date2025-08-22
Product TypeVitamin
FormLiquid
BrandCarlson
DSLD ID337604
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.